Cite

HARVARD Citation

    Wang, M. et al. (n.d.). S958 Pharmacogene CYP1A2*1F Polymorphism Lowers Anti-TNF (infliximab) Response in Inflammatory Bowel Disease Patients. American journal of gastroenterology. p. S458. [Online]. 
  
Back to record